Oncology
Prostate Cancer Treatment Is Creating a Metabolic Bill
A large JAMA Oncology study found metabolic abnormalities were frequently documented within the first year after men started ADT plus androgen receptor pathway inhibitor therapy. The survival gains are real. So is the cardiometabolic debt.
Hodgkin Lymphoma Survivors Are Still Paying for Cure
FDA Is Asking the Right AI Question: Who Watches the Model After Approval?
Endometrial Cancer Prehab Should Not Be a Luxury Experiment
Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era
Radiopharmaceuticals Just Got a Necessary No
Ovarian Cancer May Finally Have a Way to Drug p53
Medical Debt Is Becoming a Cancer Stage
Lymphoma Is Testing How Far Chemo-Free Care Can Go
Cancer Survivorship Standards Are Still Mostly Paper
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.